Contingency Management in the NCR. Monday, May 12, 2014

the Joint Force Headquarters Military District of Washington’s (JFHQ/MDW) 8^th Annual Interagency Chaplaincy Conference -which will be held on Monday, May 12, 2014 at the Spates Club at Fort Myer.  It will be a full days training and the topic will be “Contingency Management in the NCR - How Do Civil Authorities and the Military Work Together / What Does It Look Like”.

            This is a very important regional topic and we look forward to once again seeing everyone!  Registration and additional information will SOON follow.

____________________________________________________

SAVE THE DATE

Joint Force Headquarters Military District of Washington (JFHQ/MDW)

8th Annual Interagency Chaplaincy Conference

-        Contingency Management in the NCR -

How Do Civil Authorities and the Military Work Together / What Does It Look Like

Spates Club at Fort Myer

Monday, May 12, 2014

SAVE THE DATE

Drug Manufacturing Shortages within the U.S. February 2014.

What's New on the FDA Drugs Site
February 3, 2014

• Current Drug Shortages Index (updated)
• Drugs to be Discontinued: Calcitriol Injection
• Resolved Drug Shortages: Hydromorphone Hydrochloride Tablets
• Resolved Drug Shortages: Isoniazid; Rifampin (Rifamate) Capsules
• Resolved Drug Shortages: Levothyroxine sodium (Levoxyl) Tablets 
• Drug Firm Annual Registration Status (updated)
• Drug Firm Annual Registration Status Download File (updated)
• FDA approves Hetlioz (tasimelteon): first treatment for non-24 hour sleep-wake disorder in blind individuals
• National Drug Code Directory

---

New and Generic Drug Approvals
January 31, 2014

Drug Name	Active Ingredient	Dosage Form/Route	Sponsor	Submission Type
Acthrel	corticorelin ovine triflutate	Injectable;Injection	Ferring	Manufacturing Change or Addition
Atazanavir Sulfate	atazanavir sulfate	Capsule; Oral	Aurobindo Pharma Ltd	Tentative Approval
Children's Allegra Allergy	fexofenadine hydrochloride	Tablet, Orally Disintegrating;Oral	Sanofi Aventis Us	Manufacturing Change or Addition
Children's Allegra Hives	fexofenadine hydrochloride	Tablet, Orally Disintegrating;Oral	Sanofi Aventis Us	Manufacturing Change or Addition
Glucophage Xr	metformin hydrochloride	Tablet, Extended Release;Oral	Bristol Myers Squibb	Manufacturing Change or Addition
Hetlioz	tasimelteon	Capsule; Oral	Vanda Pharmaceuticals Inc	Approval
Humalog	insulin lispro recombinant	Injectable;Injection	Lilly	Manufacturing Change or Addition
Humalog Kwikpen	insulin lispro recombinant	Injectable;Injection	Lilly	Manufacturing Change or Addition
Humalog Pen	insulin lispro recombinant	Injectable;Injection	Lilly	Manufacturing Change or Addition
Kyprolis	carfilzomib	Powder;Intravenous	Onyx Pharms	Manufacturing Change or Addition
Letairis	ambrisentan	Tablet;Oral	Gilead	Labeling Revision
Oxycontin	oxycodone hydrochloride	Tablet, Extended Release;Oral	Purdue Pharma Lp	Manufacturing Change or Addition
Propecia	finasteride	Tablet;Oral	Merck	Labeling Revision
Pytest	urea, c-14	Capsule;Oral	Avent	Manufacturing Change or Addition
Pytest Kit	urea, c-14	Capsule;Oral	Avent	Manufacturing Change or Addition
Revatio	sildenafil citrate	Tablet;Oral	Pfizer	Efficacy Supplement with Clinical Data to Support
Revatio	sildenafil citrate	Tablet;Oral	Pfizer	Labeling Revision
Revatio	sildenafil citrate	Solution;Intravenous	Pfizer	Efficacy Supplement with Clinical Data to Support
Revatio	sildenafil citrate	Solution;Intravenous	Pfizer	Labeling Revision
Revatio	sildenafil citrate	For Suspension;Oral	Pfizer	Efficacy Supplement with Clinical Data to Support
Revatio	sildenafil citrate	For Suspension;Oral	Pfizer	Labeling Revision
Salonpas	menthol; methyl salicylate	Patch;Topical	Hisamitsu Pharm Co	Manufacturing Change or Addition
Septocaine	articaine hydrochloride; epinephrine bitartrate	Injectable;Injection	Deproco	Manufacturing Change or Addition
Zetonna	ciclesonide	Aerosol, Metered;Nasal	Takeda Gmbh	Manufacturing Change or Addition

---